PLN 58.6
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Established in 2012 and headquartered in Warsaw, Poland, Medinice S.A. specializes in delivering advanced medical solutions for the fields of cardiology and cardiac surgery. The company actively assists scientists in the complex journey of bringing new products to market, offering comprehensive support that spans prototyping, conducting clinical trials, securing essential certifications, and overseeing product sales.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.
Data is available to registered users only